27:
227:
Neich
Medical continued its international expansion in 2005 by acquiring its longstanding partner Orbus Medical Technologies Inc., a company with strong ties in the European medical community, whose main business was the research and development of interventional medical devices, pioneering the
365:
193:(EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent. Several trials including a randomized study dedicated to patients with
224:
By 2001, the company had obtained license approval for the sale of its first balloon catheter product in China and the
European Union markets. Other balloon catheters soon followed.
250:
In addition to PCI/PTA balloons and coronary stent products, the company is actively expanding into neuro-vascular intervention and structural heart disease areas.
424:
429:
189:
In 2013, OrbusNeich received CE mark for the world's first and only dual therapy stent, the COMBO Dual
Therapy Stent. The COMBO Stent features active
174:
190:
306:. A distributor network is covering more than 70 countries across six continents. The company has a production and
391:
198:
315:
307:
235:
Over the years, OrbusNeich has brought to market a range of stent and balloon devices, including a series of
244:
197:(ACS) and registries with a sizeable ACS patient subset demonstrated consistently low event rates and short
194:
339:
37:
217:, China, in 2000 to begin the research and development of interventional medical devices, including
352:
378:
218:
136:
266:
OrbusNeich is represented throughout the world. The
Corporate Headquarters are located in
183:
229:
59:
418:
45:
26:
338:(January 2010). "OrbusNeich, a company providing stent technology for the future."
295:
236:
319:
275:
271:
267:
210:
77:
404:
311:
279:
214:
291:
247:, for both the treatment of coronary and peripheral vascular disease.
89:
Teddy Chien (Founder), David Chien (Chairman and CEO), Denise Lau (COO)
303:
240:
299:
287:
283:
97:
182:) is a company that designs, develops, manufactures and markets
163:
142:
314:, China, an advanced research & development facility in
151:
166:
119:
239:
balloon catheters for the management of the most complex
258:
OrbusNeich owns more than 180 granted patents globally.
131:
OrbusNeich
Medical Group Holdings Limited (OrbusNeich)
213:, China, established its manufacturing facilities in
175:
160:
154:
139:
318:, Florida, USA and further production facilities in
148:
145:
157:
114:
104:
93:
83:
73:
65:
55:
43:
33:
379:Catheterization & Cardiovascular Interventions
8:
270:, and direct sales teams are operating from
19:
232:platform, thus forming OrbusNeich Medical.
25:
18:
209:Neich Medical, with its headquarters in
186:for the treatment of vascular diseases.
331:
16:Hong-Kong based medical devices company
425:Medical technology companies of China
7:
430:Manufacturing companies of Hong Kong
392:JACC: Cardiovascular Interventions
60:Medical Instruments & Supplies
14:
390:M. Haude et al., REMEDEE Trial,
364:G. de Luca et al, REDUCE Study,
135:
201:option of 3 months, if needed.
1:
228:design of the dual helical
191:endothelial progenitor cell
446:
351:S. Saito, HARMONEE Study,
308:research & development
24:
405:"About Us - OrbusNeich"
377:L.S. Kerkmeijer et al.
245:chronic total occlusion
195:Acute Coronary Syndrome
353:European Heart Journal
340:European Heart Journal
322:, The Netherlands.
106:Number of employees
21:
219:balloon catheters
128:
127:
437:
409:
408:
401:
395:
388:
382:
375:
369:
366:EuroIntervention
362:
356:
349:
343:
336:
179:
173:
172:
169:
168:
165:
162:
159:
156:
153:
150:
147:
144:
141:
124:
121:
29:
22:
445:
444:
440:
439:
438:
436:
435:
434:
415:
414:
413:
412:
403:
402:
398:
389:
385:
381:, October 2020.
376:
372:
363:
359:
350:
346:
337:
333:
328:
316:Fort Lauderdale
264:
256:
207:
184:medical devices
177:
138:
134:
118:
107:
86:
48:
17:
12:
11:
5:
443:
441:
433:
432:
427:
417:
416:
411:
410:
396:
383:
370:
368:, August 2019.
357:
344:
330:
329:
327:
324:
263:
260:
255:
252:
230:coronary stent
206:
203:
126:
125:
116:
112:
111:
108:
105:
102:
101:
95:
91:
90:
87:
84:
81:
80:
75:
71:
70:
67:
63:
62:
57:
53:
52:
49:
44:
41:
40:
35:
31:
30:
15:
13:
10:
9:
6:
4:
3:
2:
442:
431:
428:
426:
423:
422:
420:
406:
400:
397:
394:, April 2013.
393:
387:
384:
380:
374:
371:
367:
361:
358:
355:, April 2018.
354:
348:
345:
341:
335:
332:
325:
323:
321:
317:
313:
309:
305:
301:
297:
293:
289:
285:
281:
277:
273:
269:
261:
259:
253:
251:
248:
246:
242:
238:
233:
231:
225:
222:
220:
216:
212:
204:
202:
200:
196:
192:
187:
185:
181:
180:
171:
132:
123:
117:
113:
109:
103:
99:
96:
92:
88:
82:
79:
76:
72:
68:
64:
61:
58:
54:
50:
47:
42:
39:
36:
32:
28:
23:
399:
386:
373:
360:
347:
334:
310:facility in
265:
257:
249:
243:, including
234:
226:
223:
208:
188:
130:
129:
74:Headquarters
34:Company type
296:Switzerland
237:angioplasty
419:Categories
326:References
320:Hoevelaken
120:orbusneich
85:Key people
51:HKEX: 6929
20:OrbusNeich
276:Singapore
272:Hong Kong
268:Hong Kong
262:Locations
211:Hong Kong
100:, balloon
78:Hong Kong
46:Traded as
312:Shenzhen
280:Malaysia
254:Products
215:Shenzhen
94:Products
56:Industry
292:Germany
241:lesions
205:History
176:or-bəs-
115:Website
66:Founded
304:France
38:Public
300:Spain
284:Japan
178:NEESH
98:Stent
302:and
199:DAPT
122:.com
110:500+
69:2000
288:PRC
221:.
421::
298:,
294:,
290:,
286:,
282:,
278:,
274:,
164:iː
143:ɔː
407:.
342:.
170:/
167:ʃ
161:n
158:ˈ
155:s
152:ə
149:b
146:r
140:ˌ
137:/
133:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
